Mr. Brian A. Markison, CPA, is a Chairman & Chief Executive Officer at Osmotica Holdings Corp. Ltd., a Chairman & Chief Executive Officer at Osmotica Pharmaceuticals Plc, a Chairman at Lantheus Medical Imaging, Inc., a Non-Executive Chairman at Lantheus Holdings, Inc. and a Chief Executive Officer at Osmotica Pharmaceutical Corp.
He is on the Board of Directors at Acp Nimble Holdings, Inc., Braeburn Pharmaceuticals, Inc., Cosette Pharmaceuticals, Inc., Komen Central & South Jersey, National Spine & Pain Centers Holdings LLC, National Spine Center, The Pennington School and The College of New Jersey. Mr. Markison was previously employed as an Independent Director by Avista Healthcare Public Acquisition Corp., an Executive Chairman by Vertical/Trigen Holdings LLC, an Executive Chairman by Vertical Pharmaceuticals LLC, an Independent Director by Alere, Inc., an Independent Director by PharmAthene, Inc., a President, Chief Executive Officer & Director by Fougera Pharmaceuticals, Inc., a Chairman by Rosetta Genomics Ltd., a Lead Independent Director by Immunomedics, Inc., a Chief Operating Officer by King Pharmaceuticals, Inc., a President-Oncology & Virology by Bristol-Myers Squibb Co., and a President by Oncology Therapeutics Network Corp.
He also served on the board at Theraclone Sciences, Inc.
He received his undergraduate degree from Iona College.